Cargando…
Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study
INTRODUCTION: Little information is available on the temporal trends in the clinical epidemiology and in-hospital mortality of patients with coronavirus disease 2019 (COVID-19) in Japan for waves 1, 2, and 3. METHODS: A national claims database was used to analyze the time trends in admission, medic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239980/ https://www.ncbi.nlm.nih.gov/pubmed/35779801 http://dx.doi.org/10.1016/j.jiac.2022.06.013 |
_version_ | 1784737435479965696 |
---|---|
author | Endo, Hideki Lee, Kyunghee Ohnuma, Tetsu Watanabe, Senri Fushimi, Kiyohide |
author_facet | Endo, Hideki Lee, Kyunghee Ohnuma, Tetsu Watanabe, Senri Fushimi, Kiyohide |
author_sort | Endo, Hideki |
collection | PubMed |
description | INTRODUCTION: Little information is available on the temporal trends in the clinical epidemiology and in-hospital mortality of patients with coronavirus disease 2019 (COVID-19) in Japan for waves 1, 2, and 3. METHODS: A national claims database was used to analyze the time trends in admission, medical procedure, and in-hospital mortality characteristics among patients with COVID-19. Patients who were ≥18 years and discharged from January 1, 2020 to February 28, 2021 were included. RESULTS: A multilevel logistic regression analysis of 51,252 patients revealed a decline in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.17–4.07%; relative risk reduction = 23–59%; reference month of April 2020 = 5.32%). In the subgroup analysis, a decline in mortality was also observed in patients requiring oxygen support but not mechanical ventilation (risk-adjusted mortality range = 5.98–11.68%; relative risk reduction = 22–60%; reference month of April 2020 = 15.06%). Further adjustments for medical procedure changes in the entire study population revealed a decrease in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.66–4.05%; relative risk reduction = 24–50%). CONCLUSIONS: A decline in in-hospital mortality was observed in waves 2 and 3 after adjusting for patient/hospital-level characteristics and medical treatments. The reasons for this decline warrant further research to improve the outcomes of hospitalized patients. |
format | Online Article Text |
id | pubmed-9239980 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92399802022-06-29 Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study Endo, Hideki Lee, Kyunghee Ohnuma, Tetsu Watanabe, Senri Fushimi, Kiyohide J Infect Chemother Original Article INTRODUCTION: Little information is available on the temporal trends in the clinical epidemiology and in-hospital mortality of patients with coronavirus disease 2019 (COVID-19) in Japan for waves 1, 2, and 3. METHODS: A national claims database was used to analyze the time trends in admission, medical procedure, and in-hospital mortality characteristics among patients with COVID-19. Patients who were ≥18 years and discharged from January 1, 2020 to February 28, 2021 were included. RESULTS: A multilevel logistic regression analysis of 51,252 patients revealed a decline in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.17–4.07%; relative risk reduction = 23–59%; reference month of April 2020 = 5.32%). In the subgroup analysis, a decline in mortality was also observed in patients requiring oxygen support but not mechanical ventilation (risk-adjusted mortality range = 5.98–11.68%; relative risk reduction = 22–60%; reference month of April 2020 = 15.06%). Further adjustments for medical procedure changes in the entire study population revealed a decrease in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.66–4.05%; relative risk reduction = 24–50%). CONCLUSIONS: A decline in in-hospital mortality was observed in waves 2 and 3 after adjusting for patient/hospital-level characteristics and medical treatments. The reasons for this decline warrant further research to improve the outcomes of hospitalized patients. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022-10 2022-06-29 /pmc/articles/PMC9239980/ /pubmed/35779801 http://dx.doi.org/10.1016/j.jiac.2022.06.013 Text en © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Endo, Hideki Lee, Kyunghee Ohnuma, Tetsu Watanabe, Senri Fushimi, Kiyohide Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study |
title | Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study |
title_full | Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study |
title_fullStr | Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study |
title_full_unstemmed | Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study |
title_short | Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study |
title_sort | temporal trends in clinical characteristics and in-hospital mortality among patients with covid-19 in japan for waves 1, 2, and 3: a retrospective cohort study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239980/ https://www.ncbi.nlm.nih.gov/pubmed/35779801 http://dx.doi.org/10.1016/j.jiac.2022.06.013 |
work_keys_str_mv | AT endohideki temporaltrendsinclinicalcharacteristicsandinhospitalmortalityamongpatientswithcovid19injapanforwaves12and3aretrospectivecohortstudy AT leekyunghee temporaltrendsinclinicalcharacteristicsandinhospitalmortalityamongpatientswithcovid19injapanforwaves12and3aretrospectivecohortstudy AT ohnumatetsu temporaltrendsinclinicalcharacteristicsandinhospitalmortalityamongpatientswithcovid19injapanforwaves12and3aretrospectivecohortstudy AT watanabesenri temporaltrendsinclinicalcharacteristicsandinhospitalmortalityamongpatientswithcovid19injapanforwaves12and3aretrospectivecohortstudy AT fushimikiyohide temporaltrendsinclinicalcharacteristicsandinhospitalmortalityamongpatientswithcovid19injapanforwaves12and3aretrospectivecohortstudy |